Premium
REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE PROGRAM
Author(s) -
Thieblemont C.,
Le Gouill S.,
Di Blasi R.,
Cartron G.,
Morschhauser F.,
Bachy E.,
Paillassa J.,
Bernard S.,
Tessoulin B.,
Gastine T.,
Fegueux N.,
Kanouni T.,
Manier S.,
Sesques P.,
Houot R.,
Haouin C.,
Tilly H.,
Salles G.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.110_2630
Subject(s) - medicine , refractory (planetary science) , diffuse large b cell lymphoma , chimeric antigen receptor , gastroenterology , lymphoma , progressive disease , surgery , oncology , disease , cancer , immunotherapy , physics , astrobiology